Disclosure Policy
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all relevant conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Special Services
Registration Fees:
MD/DO through 3/15: $50
Allied Health Professionals through 3/15: $30
Residents/Fellows: $0 - please email Lori at ARC to register
If you require special assistance to attend this event, please call (617) 358-5005 or email cme@bu.edu.
Overview
Boston University School of Medicine (BUSM) and the Amyloidosis Research Consortium (ARC) have partnered to provide a 1-day virtual, live stream AMA PRA-accredited conference. This will be an exciting, interactive educational event where attendees will learn about amyloidosis care and be able to connect with experts in the field. This conference will be open to all specialties, but will be primarily targeted to practicing physicians and nurses that most commonly see and treat amyloidosis patients.
Led by an internationally renowned faculty team of amyloidosis experts, this conference will spotlight various aspects of the diagnosis, treatment and long-term management of amyloidosis. Attending clinicians will learn skills to identify, correctly diagnose, and treat amyloidosis patients in their clinical practice, as well as when and how to refer to specialty centers. The attendees will also learn about the value of multidisciplinary teams, and how to build an amyloidosis program to best support patients.
CME Course Director:
Vaishali Sanchorawala, MD
Professor of Medicine, Boston University School of Medicine - Director, Autologous Stem Cell Transplant Program; Director, Amyloidosis Center
Speakers
Sascha Tuchman, MD, MHS

Associate Professor; Director, Multiple Myeloma and Amyloidosis Program, University of North Carolina- Chapel Hill Comprehensive Cancer Center
View Full Bio
John Berk, MD

Associate Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine, Boston University School of Medicine
View Full Bio
Jose Nativi-Nicolau, MD

Associate Professor; Cardiovascular Director, Amyloidosis Program, University of Utah and Huntsman Cancer Institute
View Full Bio
Vaishali Sanchorawala, MD

Director, Amyloidosis Center, Boston University School of Medicine
View Full Bio
Michael Polydefkis, MD

Professor of Neurology; Director, Cutaneous Nerve Lab, Johns Hopkins University School of Medicine
View Full Bio
Lisa Mendelson, BSN, MSN, ANP-BC

Assistant Professor of Medicine, Boston University School of Medicine
View Full Bio
David Hughes, PharmD, BCOP

Clinical Pharmacy Manager Hematology/Oncology Boston Medical Center
View Full Bio
Accreditation
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Amyloidosis Research Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by Amyloidosis Research Consortium.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.